Literature DB >> 19693793

Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.

Kanin Wichapong1, Somsak Pianwanit, Wolfgang Sippl, Sirirat Kokpol.   

Abstract

The pathogenic West Nile virus (WNV) and Dengue virus (DV) are growing global threats for which there are no specific treatments. Both viruses possess a two component NS2B/NS3 protease which cleaves viral precursor proteins. Whereas for the WNV protease two crystal structures in complex with an inhibitor have been solved recently, no such information is available for the DV protease. Here, we report the generation of a homology model of DV NS2B/NS3 protease. Since it is known from the related WNV protease that it adopts a distinct conformation in free and in inhibitor-complexed form, a special emphasis was given to the analysis of the protease flexibility. Therefore, several models of DV NS2B/NS3 protease complexed with the peptidic inhibitor (Bz-Nle(P4)-Lys(P3)-Arg(P2)-Arg(P1)-H) were generated. The first DV protease model (DV-1) was constructed using the available crystal structure of the apo DV NS2B/NS3 protease. The second model (DV-2) was built taking the WNV NS3/NS2B protease in the inhibitor-complexed form as the template structure. Molecular dynamics simulations which were carried out for the WNV crystal structures as well as for the DV models provided an understanding of the role of NS2B for maintaining the protease in the active conformation. It was also demonstrated that NS2B is not only important for maintaining NS3 in the active form, but is also essential for establishing the interaction between residues from the S2 pocket and the peptidic inhibitor. The DV NS2B/NS3 model in the productive conformation can now be used for structure-based design purposes. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19693793     DOI: 10.1002/jmr.977

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  15 in total

1.  Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.

Authors:  Sergey A Shiryaev; Anton V Cheltsov; Katarzyna Gawlik; Boris I Ratnikov; Alex Y Strongin
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

2.  Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.

Authors:  Kok-Chuan Tiew; Dengfeng Dou; Tadahisa Teramoto; Huiguo Lai; Kevin R Alliston; Gerald H Lushington; R Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2011-12-30       Impact factor: 3.641

3.  Structure-guided fragment-based in silico drug design of dengue protease inhibitors.

Authors:  Tim Knehans; Andreas Schüller; Danny N Doan; Kassoum Nacro; Jeffrey Hill; Peter Güntert; M S Madhusudhan; Tanja Weil; Subhash G Vasudevan
Journal:  J Comput Aided Mol Des       Date:  2011-02-23       Impact factor: 3.686

4.  Ligand-bound structures of the dengue virus protease reveal the active conformation.

Authors:  Christian G Noble; Cheah Chen Seh; Alexander T Chao; Pei Yong Shi
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

5.  Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.

Authors:  Sridhar Aravapalli; Huiguo Lai; Tadahisa Teramoto; Kevin R Alliston; Gerald H Lushington; Eron L Ferguson; R Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-05-10       Impact factor: 3.641

6.  Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.

Authors:  Chi-Chen Yang; Yi-Chen Hsieh; Shiow-Ju Lee; Szu-Huei Wu; Ching-Len Liao; Chang-Huei Tsao; Yu-Sheng Chao; Jyh-Haur Chern; Chung-Pu Wu; Andrew Yueh
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

7.  New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation.

Authors:  Hugo de Almeida; Izabela M D Bastos; Bergmann M Ribeiro; Bernard Maigret; Jaime M Santana
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

8.  Enzymatic analysis of recombinant Japanese encephalitis virus NS2B(H)-NS3pro protease with fluorogenic model peptide substrates.

Authors:  Muhammad Junaid; Chakard Chalayut; Anna Sehgelmeble Torrejon; Chanan Angsuthanasombat; Iryna Shutava; Maris Lapins; Jarl E S Wikberg; Gerd Katzenmeier
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Development of a NS2B/NS3 protease inhibition assay using AlphaScreen® beads for screening of anti-dengue activities.

Authors:  Muhammad Asyraf Abduraman; Maywan Hariono; Rohana Yusof; Noorsaadah Abd Rahman; Habibah A Wahab; Mei Lan Tan
Journal:  Heliyon       Date:  2018-12-08

10.  Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA.

Authors:  Vivek Kumar; M Elizabeth Sobhia
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.